Arvinas (NASDAQ: ARVN) net income
Arvinas reported a net loss of $80.8m for fiscal 2025; in fiscal 2024 it reported a net loss of $198.9m. Earnings per share were −$1.14.
Arvinas's best year of the last 9 was fiscal 2017. It reported a loss in 9 of those 9 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$80.8m | — | −30.8% | −$1.14 |
| 2024 | −$198.9m | — | −75.5% | −$2.77 |
| 2023 | −$367.3m | — | −467.9% | −$6.62 |
| 2022 | −$282.5m | — | −215.0% | −$5.31 |
| 2021 | −$191.0m | — | −356.3% | −$3.82 |
| 2020 | −$119.3m | — | −460.6% | −$3.02 |
| 2019 | −$70.3m | — | −163.5% | −$2.13 |
| 2018 | −$41.5m | — | −289.6% | — |
| 2017 | −$24.0m | — | −317.3% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Arvinas net income compared with its sector
By net income for its latest fiscal year, Arvinas ranks 316th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Arvinas, −30.8%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 314th | STAAR Surgical | −$80.4m | −33.6% |
| 315th | Bioage Labs | −$80.6m | −896.1% |
| 316th | Arvinas | −$80.8m | −30.8% |
| 317th | Zymeworks | −$81.1m | −76.6% |
| 318th | Personalis | −$81.3m | −116.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Arvinas
- How much did Arvinas earn in fiscal 2025?
- Arvinas reported a net loss of $80.8m for fiscal 2025. In fiscal 2024 it reported a net loss of $198.9m.
- What are the earnings per share of Arvinas?
- They were −$1.14 in fiscal 2025, compared with −$2.77 in fiscal 2024.
- Where does Arvinas rank in its sector by net income?
- It ranks 316th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Arvinas come from?
- From the annual report (Form 10-K) that Arvinas files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Arvinas files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Arvinas: the Arvinas page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.